Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6526-6531

  Williams, Mark S ^a   Noguchi, Soichi ^b   Henkart, Pierre A ^c   Osawa, Yoichi ^b  

^a HOLLAND LABORATORY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CD69 ANTIGEN; DEXAMETHASONE; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2; IONOMYCIN; MONOCLONAL ANTIBODY CD3; N(G) METHYL DEXTRO ARGININE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; POKEWEED MITOGEN; STAPHYLOCOCCUS ENTEROTOXIN B; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEREOSPECIFICITY; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; DEXAMETHASONE; ENZYME INHIBITORS; FAS LIGAND PROTEIN; HUMANS; HYBRIDOMAS; INDAZOLES; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TYROSINE;

EID: 0032534664     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
2. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
3. Shi, Y., B. M. Sahai, and D. R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625.
4. Anel, A., M. Buferne, C. Boyer, A.-M. Schmitt-Verhulst, and P. Golstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:2469.
5. Eischen, C. M., B. L. Williams, W. Zhang, L. E. Samelson, D. H. Lynch, R. T. Abraham, and P. J. Leibson. 1997. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159:1135.
6. Gonzalez-Garcia, A., L. R.-Borlado, E. Leonardo, I. Merida, C. Martinez-A., and A. C. Carrera. 1997. Lck is necessary and sufficient for Fas-ligand expression and apoptotic cell death in mature cycling T cells. J. Immunol. 158:4104.
7. Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158:4602.
8. Yang, Y., M. Mercep, C. F. Ware, and J. D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673.
9. Williams, M. S., and P. A. Henkart. 1996. The role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157: 2395.
10. Sandstrom, P. A., M. D. Mannie, and T. M. Buttke. 1994. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55:221.
11. Palmer, R. M., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524.
12. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
13. Jaffrey, S. R., and S. H. Snyder. 1995. Nitric oxide: a neural messenger. Annu. Rev. Cell. Dev. Biol. 11:417.
14. Schmidt, H. H. H. W., and U. Walter. 1994. NO at work. Cell 78:919.
15. Stuehr, D. J., and C. F. Nathan. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543.
16. Nathan, C. F., and J. B. Hibbs, Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
17. Bonham, C. A., L. Lu, Y. Li, R. A. Hoffman, R. L. Simmons, and A. W. Thomson. 1996. Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses. Transplantation 62:1871.
18. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080.
19. Hoffman, R. A., J. M. Langrehr, S. M. Wren, K. E. Dull, S. T. Ildstad, S. A. McCarthy, and R. L. Simmons. 1993. Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease. J. Immunol. 151:1508.
20. Taylor-Robinson, A. W., F. Y. Liew, A. Severn, D. Xu, S. J. McSorley, P. Garside, J. Padron, and R. S. Phillips. 1994. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:980.
21. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137.
22. 2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur. J. Immunol. 26:511.
23. Sciorati, C., P. Rovere, M. Ferrarini, S. Heltai, A. A. Manfredi, and E. Clementi. 1997. Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. Biol. Chem. 272:23211.
24. Sarin, A., D. H. Adams, and P. A. Henkart. 1993. Protease inhibitors selectively block T-cell receptor-triggered programmed cell death in a murine T cell hybrid-oma and activated peripheral T cells. J. Exp. Med. 178:1693.
25. Bryant, J., R. Day, T. L. Whiteside, and R. B. Herberman. 1992. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146:91.
26. Algeciras, A., D. H. Dockrell, D. H. Lynch, and C. V. Paya. 1998. CD4 regulates susceptibility to Fas ligand-and tumor necrosis factor-mediated apoptosis. J. Exp. Med. 187:711.
27. Knowles, R. G., M. Merrett, M. Salter, and S. Moncada. 1990. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270:833.
28. Osawa, Y., J. C. Davila, C. M. Meyer, and M. Nakatsuka. 1994. Mechanism based inactivation of nitric oxide synthase, a P450-like enzyme, by xenobiotics. In Cytochrome P-450: biochemistry, biophysics, and molecular biology. M. C. Lechner, ed. John Libbey Eurotext, Paris, p. 459.
29. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
30. Halliwell, B. 1997. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett. 411:157.
31. Ye, Y. Z., M. Strong, Z. Q. Huang, and J. S. Beckman. 1996. Antibodies that recognize nitrotyrosine. Methods Enzymol. 269:201.
32. Fehsel, K., K. D. Kroncke, K. L. Meyer, H. Huber, V. Wahn, and V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:2858.
33. + content, and p53 accumulation. Arch. Biochem. Biophys. 327:1.
34. Genaro, A. M., S. Hortelano, A. Alvarez, C. Martinez, and L. Bosca. 1995. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest. 95:1884.
35. Dimmeler, S., J. Haendeler, M. Nehls, and A. M. Zeiher. 1997. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185:601.
36. Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931.
37. Lander, H. M., D. P. Hajjar, B. L. Hempstead, U. A. Mirza, B. T. Chait, S. Campbell, and L. A. Quilliam. 1997. A molecular redox switch on p21(ras): structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:4323.
38. Peng, H. B., P. Libby, and J. K. Liao. 1995. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:14214.
39. Peunova, N., and G. Enikolopov. 1993. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. [Published erratum appears in 1993 Nature 365:468.] Nature 364:450.
40. Beckman, J. S., and W. H. Koppenol. 1996. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:C1424.
41. Van der Vliet, A., J. P. Eiserich, H. Kaur, C. E. Cross, and B. Halliwell. 1996. Nitrotyrosine as biomarker for reactive nitrogen species. Methods Enzymol. 269: 175.
42. MacMillan-Crow, L. A., J. P. Crow, J. D. Kerby, J. S. Beckman, and J. A. Thompson. 1996. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA 93:11853.
43. Kong, S. K., M. B. Yim, E. R. Stadtman, and P. B. Chock. 1996. Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide. Proc. Natl. Acad. Sci. USA 93:3377.
44. + population after activation. Immunology 82:357.
45. Chinnaiyan, A. M., and V. M. Dixit. 1997. Portrait of an executioner: the molecular mechanism of FAS/APO-1-induced apoptosis. Semin. Immunol. 9:69.